This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
New AIDS drugs promise fewer pills and easy use
At the World AIDS Conference, two new medications Sustiva and Ziagen show similar effectiveness to protease inhibitors. They could reduce daily pill counts by about two thirds, offering simpler regimens for patients and expanding treatment options for those with adherence challenges. Both companies seek FDA approval based on conference data. Sustiva enables five pills daily, Ziagen three morning and three evening, with no head to head trials yet.
MENTIONED IN THIS ARTICLE
Geneva
DuPont Pharmaceuticals
Sustiva
Glaxo Wellcome
U.S. Food and Drug Administration
Schlomo Staszewski
Goethe University
Frankfurt
Germany
Douglas Richman
University of California, San Dieo